STERAMIST NOW ON EPA LIST N FOR EFFICACY AGAINST SARS CoV-2
9:30 AM ET 3/18/20 | GlobeNewswire
STERAMIST NOW ON EPA LIST N FOR EFFICACY AGAINST SARS CoV-2
BEVERLY HILLS, Calif., March 18, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.(R) ("TOMI") (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). Binary Ionization Technology(R) (BIT(TM)) Solution has qualified to meet the EPA Emerging Viral Pathogen Guidance for Antimicrobial Pesticides with the SteraMist Environment System for room fogging/misting against SARS-CoV-2, the novel coronavirus that causes COVID-19 (COVID-19).
The EPA Emerging Viral Pathogen Guidance for Antimicrobial Pesticides is important because the occurrence of emerging viral pathogens is less common and predictable than established pathogens and there are currently no other EPA-registered disinfectant product labels with claims against COVID-19. The SARS-CoV-2, the novel coronavirus that causes COVID-19 qualifies as an emerging viral pathogen. TOMI's Binary Ionization Technology (BIT) Solution, used exclusively in tandem with SteraMist equipment including the Surface Unit and Environment System, is currently listed on List G for Norovirus, List H for MRSA, List K for Clostridium difficile spores, List L for Ebola, List M for H1N1, and now List N: Disinfectants for Use Against SARS-CoV-2. With labeled efficacy for large and small enveloped viruses in addition to other pathogens, TOMI has confidence this EPA addition will support client efforts to reduce the ongoing spread of the COVID-19.
TOMI's Chief Regulatory Officer, Elizabeth Battaglia, states, "TOMI's demonstrated efficacy on a wide range of pathogens is further confirmed by the addition to the EPA list N and updated stamped label with Emerging Pathogens language. TOMI continually undertakes new studies to expand our efficacy claims."
TOMI's CEO, Dr. Halden Shane, states, "The developments behind the new SARS CoV-2 virus brings new importance to our efforts to work together with our clients in our ongoing mission to help protect life. In the wake of this difficult time, we are grateful to be able to serve customers, protect communities, and help individuals all over the world."
Please refer to the EPA website for additional information: www.epa.gov
TOMI(TM) Environmental Solutions, Inc.: Innovating for a safer world(R)
